Skip to main content

Table 2 Association between SNPs in SLC52A3 and ESCC risk in the Chinese population (NESCC = 479, Ncontrol = 479)

From: Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients

Genotype ESCC Control OR (95 % CI) P
N (%) N (%)
rs13042395
 CC 135 (28.18) 147 (30.69) 1.00 (reference)  
 CT 236 (49.27) 218 (45.51) 1.18 (0.88–1.59) 0.28
 TT 108 (22.55) 114 (23.80) 1.03 (0.73–1.47) 0.86
 CT + TT 344 (71.82) 332 (69.31) 1.14 (0.86–1.50) 0.36
 CC + CT 371 (77.45) 365 (76.20) 1.00 (reference)  
 TT 108 (22.55) 114 (23.80) 0.93 (0.69–1.26) 0.65
rs3746803
 GG 425 (88.73) 424 (88.52) 1.00 (reference)  
 GA 55 (11.48) 53 (11.06) 1.00 (0.67–1.49) 0.99
 AA 1 (0.21) 2 (0.42) 0.50 (0.05–5.52) 0.57
 GA + AA 54 (11.27) 55 (11.48) 0.98 (0.66–1.46) 0.92
 GG + GA 478 (99.79) 477 (99.58) 1.00 (reference)  
 AA 1 (0.21) 2 (0.42) 0.50 (0.05–5.52) 0.57
  1. All associations are significant at P < 0.05
  2. SNP single nucleotide polymorphism, ESCC esophageal squamous cell carcinoma, OR odds ratio, 95 % CI 95 % confidence interval